Sanitar Co., Ltd. (1817.TW)
TWD 40.85
(-0.61%)
TWD 40.85
(-0.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 401.77 Million TWD | -20.28% |
| 2022 | 503.97 Million TWD | 23.39% |
| 2021 | 407.37 Million TWD | -0.34% |
| 2020 | 407.49 Million TWD | 19.23% |
| 2019 | 341.87 Million TWD | -17.73% |
| 2018 | 417.68 Million TWD | 5.26% |
| 2017 | 396.95 Million TWD | 1.07% |
| 2016 | 392.73 Million TWD | 4.66% |
| 2015 | 375.25 Million TWD | 28.54% |
| 2014 | 291.92 Million TWD | 7.42% |
| 2013 | 271.75 Million TWD | 47.64% |
| 2012 | 183 Million TWD | -3.68% |
| 2011 | 191.25 Million TWD | -6.26% |
| 2010 | 251.68 Million TWD | 25.52% |
| 2009 | 162.41 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 101.43 Million TWD | -29.7% |
| 2024 Q2 | 124.63 Million TWD | 22.87% |
| 2023 Q3 | 107.16 Million TWD | 12.59% |
| 2023 Q1 | 71.97 Million TWD | -47.03% |
| 2023 Q2 | 95.17 Million TWD | 32.24% |
| 2023 FY | - TWD | -20.28% |
| 2023 Q4 | 144.29 Million TWD | 34.65% |
| 2022 Q3 | 138.02 Million TWD | 7.05% |
| 2022 Q1 | 101.13 Million TWD | -9.32% |
| 2022 FY | - TWD | 23.39% |
| 2022 Q4 | 135.88 Million TWD | -1.55% |
| 2022 Q2 | 128.92 Million TWD | 27.48% |
| 2021 Q3 | 90.05 Million TWD | -14.1% |
| 2021 Q2 | 104.83 Million TWD | 2.76% |
| 2021 Q1 | 102.02 Million TWD | -10.34% |
| 2021 Q4 | 111.53 Million TWD | 23.85% |
| 2021 FY | - TWD | -0.34% |
| 2020 FY | - TWD | 19.23% |
| 2020 Q1 | 74.65 Million TWD | -27.64% |
| 2020 Q2 | 95.93 Million TWD | 28.51% |
| 2020 Q3 | 125.45 Million TWD | 30.77% |
| 2020 Q4 | 113.78 Million TWD | -9.3% |
| 2019 Q2 | 73.91 Million TWD | -5.99% |
| 2019 Q1 | 78.62 Million TWD | -32.41% |
| 2019 FY | - TWD | -17.73% |
| 2019 Q4 | 103.16 Million TWD | 17.19% |
| 2019 Q3 | 88.03 Million TWD | 19.1% |
| 2018 FY | - TWD | 5.26% |
| 2018 Q4 | 116.32 Million TWD | 10.44% |
| 2018 Q3 | 105.32 Million TWD | 7.04% |
| 2018 Q2 | 98.4 Million TWD | 0.66% |
| 2018 Q1 | 97.75 Million TWD | -10.76% |
| 2017 Q1 | 77.4 Million TWD | -36.26% |
| 2017 Q2 | 104.25 Million TWD | 34.7% |
| 2017 Q3 | 105.75 Million TWD | 1.43% |
| 2017 Q4 | 109.54 Million TWD | 3.58% |
| 2017 FY | - TWD | 1.07% |
| 2016 FY | - TWD | 4.66% |
| 2016 Q4 | 121.42 Million TWD | 20.32% |
| 2016 Q1 | 77.11 Million TWD | -32.59% |
| 2016 Q2 | 93.28 Million TWD | 20.97% |
| 2016 Q3 | 100.91 Million TWD | 8.18% |
| 2015 Q2 | 83.28 Million TWD | 21.07% |
| 2015 FY | - TWD | 28.54% |
| 2015 Q4 | 114.39 Million TWD | 5.16% |
| 2015 Q3 | 108.78 Million TWD | 30.61% |
| 2015 Q1 | 68.78 Million TWD | -21.53% |
| 2014 Q1 | 49.79 Million TWD | -42.04% |
| 2014 FY | - TWD | 7.42% |
| 2014 Q2 | 68.54 Million TWD | 37.65% |
| 2014 Q4 | 87.66 Million TWD | 2.03% |
| 2014 Q3 | 85.91 Million TWD | 25.34% |
| 2013 FY | - TWD | 47.64% |
| 2013 Q4 | 85.91 Million TWD | 25.27% |
| 2013 Q2 | 61.86 Million TWD | 11.68% |
| 2013 Q1 | 55.39 Million TWD | -17.94% |
| 2013 Q3 | 68.58 Million TWD | 10.86% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 Q4 | 67.5 Million TWD | 34.59% |
| 2012 Q3 | 50.15 Million TWD | 0.0% |
| 2012 FY | - TWD | -3.68% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | - TWD | -6.26% |
| 2011 Q2 | - TWD | 0.0% |
| 2010 FY | - TWD | 25.52% |
| 2010 Q4 | - TWD | 0.0% |
| 2009 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Farcent Enterprise Co.,Ltd | 355.04 Million TWD | -13.161% |
| Mao Bao Inc. | 9.01 Million TWD | -4356.761% |
| Taiyen Biotech Co., Ltd. | 518.26 Million TWD | 22.477% |
| Chlitina Holding Limited | 1.96 Billion TWD | 79.593% |
| Jourdeness Group Limited | 802.68 Million TWD | 49.946% |
| Nan Liu Enterprise Co., Ltd. | 798.8 Million TWD | 49.703% |
| Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | -232.859% |
| San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | -19.429% |
| Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | 75.956% |
| KNH Enterprise Co., Ltd. | 1.41 Billion TWD | 71.617% |